Genmab — Oktober 2013
-
giv dem en bogus emailadresse og få adgang til artikeln
-
absolut - ADC/TAP her - fremtiden i cancer er kombinationsbehandlinger og antibodies er centrale i den udvikling
-
-
Det er også på høje tide at den kommer afsted - Vi får dog den "brede" ansøgning lige som i europa, så lidt nyhed er der over ansøgningen
-
Tror nok, at denne er ny. Fra DuoBody hjemmesiden: https://www.landesbioscience.com/journals/mabs/2013MABS0405R.pdf
-
http://www.nature.com/leu/journal/v27/n1/full/leu2012150a.html lidt gammel og måske vist før. Læsning til en weekend.
-
http://www.eijkmanschool.org/research/index.php?id=532 lidt om IgA isotypen
-
-
zlutprutmab
-
Det er DAHANCA der er dårlige ?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind